Hillsdale Investment Management Inc. Harmony Biosciences Holdings, Inc. Transaction History
Hillsdale Investment Management Inc.
- $1.21 Billion
- Q3 2024
A detailed history of Hillsdale Investment Management Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 67,700 shares of HRMY stock, worth $2.37 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
67,700
Previous 66,800
1.35%
Holding current value
$2.37 Million
Previous $2.02 Million
34.19%
% of portfolio
0.22%
Previous 0.18%
Shares
6 transactions
Others Institutions Holding HRMY
# of Institutions
242Shares Held
45.1MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$392 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$204 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$121 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$91.1 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$67.4 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.07B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...